Huntington National Bank’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8 | Hold |
1
| – | – | ﹤0.01% | 3815 |
|
|
2025
Q4 | $12 | Hold |
1
| – | – | ﹤0.01% | 3605 |
|
|
2025
Q3 | $9 | Hold |
1
| – | – | ﹤0.01% | 3741 |
|
|
2025
Q2 | $6 | Hold |
1
| – | – | ﹤0.01% | 3825 |
|
|
2025
Q1 | $5 | Hold |
1
| – | – | ﹤0.01% | 3876 |
|
|
2024
Q4 | $10 | Hold |
1
| – | – | ﹤0.01% | 3730 |
|
|
2024
Q3 | $8 | Sell |
1
-40
| -98% | -$364 | ﹤0.01% | 3782 |
|
|
2024
Q2 | $280 | Hold |
41
| – | – | ﹤0.01% | 2529 |
|
|
2024
Q1 | $104 | Buy |
41
+40
| +4,000% | +$90 | ﹤0.01% | 2505 |
|
|
2023
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3693 |
|
|
2023
Q3 | $3 | Sell |
1
-31
| -97% | -$172 | ﹤0.01% | 3638 |
|
|
2023
Q2 | $235 | Buy |
32
+31
| +3,100% | +$287 | ﹤0.01% | 2287 |
|
|
2023
Q1 | $10 | Hold |
1
| – | – | ﹤0.01% | 3237 |
|
|
2022
Q4 | $12 | Hold |
1
| – | – | ﹤0.01% | 3042 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2108 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2134 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2120 |
|
|
2021
Q4 | $0 | Sell |
1
-1,020
| -100% | -$46.1K | ﹤0.01% | 2089 |
|
|
2021
Q3 | $51K | Sell |
1,021
-86
| -8% | -$5.21K | ﹤0.01% | 965 |
|
|
2021
Q2 | $70K | Sell |
1,107
-220
| -17% | -$14.1K | ﹤0.01% | 844 |
|
|
2021
Q1 | $123K | Buy |
1,327
+30
| +2% | +$3.07K | ﹤0.01% | 590 |
|
|
2020
Q4 | $116K | Buy |
1,297
+60
| +5% | +$5.51K | ﹤0.01% | 594 |
|
|
2020
Q3 | $128K | Sell |
1,237
-70
| -5% | -$7.55K | ﹤0.01% | 567 |
|
|
2020
Q2 | $103K | Buy |
1,307
+243
| +23% | +$18.1K | ﹤0.01% | 600 |
|
|
2020
Q1 | $62K | Sell |
1,064
-219
| -17% | -$12.6K | ﹤0.01% | 718 |
|
|
2019
Q4 | $69K | Sell |
1,283
-162
| -11% | -$8.79K | ﹤0.01% | 828 |
|
|
2019
Q3 | $76K | Sell |
1,445
-1,599
| -53% | -$74.5K | ﹤0.01% | 721 |
|
|
2019
Q2 | $147K | Buy |
3,044
+112
| +4% | +$5.37K | ﹤0.01% | 574 |
|
|
2019
Q1 | $148K | Buy |
2,932
+299
| +11% | +$17.6K | ﹤0.01% | 574 |
|
|
2018
Q4 | $156K | Buy |
2,633
+374
| +17% | +$24.1K | ﹤0.01% | 554 |
|
|
2018
Q3 | $149K | Sell |
2,259
-138
| -6% | -$8.05K | ﹤0.01% | 611 |
|
|
2018
Q2 | $121K | Sell |
2,397
-27
| -1% | -$1.41K | ﹤0.01% | 671 |
|
|
2018
Q1 | $128K | Buy |
2,424
+873
| +56% | +$43.5K | ﹤0.01% | 683 |
|
|
2017
Q4 | $72K | Buy |
+1,551
| New | +$65.3K | ﹤0.01% | 867 |
|
|
2016
Q2 | – | Sell |
-685
| Closed | -$20K | – | 1547 |
|
|
2016
Q1 | $20K | Buy |
+685
| New | +$24.2K | ﹤0.01% | 1356 |
|
|
2015
Q4 | – | Sell |
-586
| Closed | -$17K | – | 1658 |
|
|
2015
Q3 | $17K | Sell |
586
-79
| -12% | -$2.6K | ﹤0.01% | 1315 |
|
|
2015
Q2 | $22K | Sell |
665
-20
| -3% | -$620 | ﹤0.01% | 1330 |
|
|
2015
Q1 | $20K | Buy |
+685
| New | +$19.6K | ﹤0.01% | 1360 |
|
Other funds holding EBS
VCM
PCM
VPM
Huntington National Bank's EBS Position: Q1 2026 in Review
Huntington National Bank held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #3815.
Huntington National Bank first reported a position in EBS in Q1 2015 and has held it in 38 quarters since. The position peaked at $156K in Q4 2018. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Huntington National Bank held 1 share of Emergent Biosolutions worth $8 as of Q1 2026.
- Huntington National Bank left its Emergent Biosolutions share count unchanged in Q1 2026.
- Emergent Biosolutions made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3815 holding.
- Huntington National Bank first reported a position in Emergent Biosolutions in Q1 2015 and has held it in 38 quarters since.
- Huntington National Bank's Emergent Biosolutions position peaked at $156K in Q4 2018.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.